COVID-19 Vaccines 101: Frequently Asked Question

Spread the love
Listen to this article

Paul Offit, MD, director, Vaccine Education Center, and teacher of pediatrics, Kid’s Health center of Philadelphia; teacher of vaccinology, Perelman School of Medication, University of Pennsylvania.

CDC: “Vaccines: The Essentials,” “When Vaccine is Minimal, Who Gets Vaccinated First?” “Comprehending How COVID-19 Vaccines Work,” “Satisfying of the Advisory Committee on Immunization Practices (ACIP) November 23,” “Comprehending mRNA COVID-19 Vaccines.”

JAMA: “COVID-19 and mRNA Vaccines– Very first Big Test for a New Method.”

The Lancet: “Oxford-AstraZeneca COVID-19 vaccine effectiveness.”

Facebook interview: Mark Zuckerberg and Anthony Fauci, MD, Nov. 30, 2020.

FDA: “Vaccines and Associated Biological Products Advisory Committee Satisfying, Dec. 17, 2020.”

Naor Bar-Zeev, PhD, associate teacher of worldwide health and vaccinology and deputy director, International Vaccine Gain Access To Center, Johns Hopkins Bloomberg School of Public Health, Baltimore. “The Expense Per Jab of Covid-19 Vaccine Prospects.”

AstraZeneca: “COVID-19 vaccine AZD1222 is much better endured in older grownups than more youthful grownups with comparable immune reactions throughout any age groups.”

The Lancet: “Security and immunogenicity of ChAdOx1nCoV-19 in a prime-boost program in young and old grownups (COV002) in a single-blind, randomized, managed, stage 2/3 trial.”

Moderna: “Moderna’s COVID-19 Vaccine Prospect Fulfills its Main Effectiveness Endpoint in the First Interim Analysis of the Stage 3 COVE Research Study.” “Covid-19: Moderna vaccine is almost 95% reliable, trial including high threat and senior individuals programs.”

CBS News: “UK alerts versus providing Pfizer vaccine to individuals vulnerable to serious allergies.”

Source link .

Download PDF

Be the first to comment

Leave a Reply

Your email address will not be published.